{"entity":{"id":"hospital-del-mar","kind":"institution","name":"Hospital del Mar / Hospital del Mar Research Institute","aka":["IMIM","Parc de Salut Mar"],"tldr":"Barcelona's seaside university hospital, whose research institute under Joaquín Arribas leads HER2 biology and CAR-T against breast cancer.","summary":"Hospital del Mar and the Hospital del Mar Research Institute (formerly IMIM) form a cancer programme with Universitat Pompeu Fabra and the Universitat Autònoma de Barcelona. Joaquín Arribas, director of the institute, characterised the truncated p95HER2 receptor and developed CAR-T and T-cell engager approaches against it, and Joan Albanell's medical oncology group is a leading breast cancer trialist within the SOLTI network. The hospital runs a comprehensive cancer service including radiotherapy, hepatobiliary surgery and haematology, an early-phase unit, and population cancer epidemiology through its public health research groups.","asOf":"2026-09-09","links":[{"label":"Hospital del Mar","url":"https://www.hospitaldelmar.cat"}],"tags":[],"related":[],"cancers":["breast-her2-positive","breast-hr-positive","colorectal"],"sections":["cell-therapy","targeted-therapy"],"technologies":["car-t","t-cell-engager","monoclonal-antibody"],"targets":["her2"],"drugs":["trastuzumab"],"companies":[],"institutions":["vall-dhebron","hospital-clinic-barcelona"],"pathways":[],"terms":[],"trials":[],"people":["joaquin-arribas","jaume-raventos-i-monjo"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Barcelona","country":"ES","lat":41.384,"lng":2.193,"institutionType":"hospital","website":"https://www.hospitaldelmar.cat","university":"Universitat Pompeu Fabra","programs":["HER2 biology and p95HER2 CAR-T","Breast cancer trials (SOLTI)","Cancer epidemiology","Early-phase trials"]},"route":"/institutions/hospital-del-mar/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"breast-her2-positive","kind":"cancer","name":"HER2-positive breast cancer","route":"/cancers/breast-her2-positive/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"}],"section":[{"id":"cell-therapy","kind":"section","name":"Cell Therapy","route":"/fronts/cell-therapy/"},{"id":"targeted-therapy","kind":"section","name":"Targeted Therapy","route":"/fronts/targeted-therapy/"}],"technology":[{"id":"car-t","kind":"technology","name":"CAR-T cell therapy","route":"/technologies/car-t/"},{"id":"monoclonal-antibody","kind":"technology","name":"Monoclonal antibodies","route":"/technologies/monoclonal-antibody/"},{"id":"t-cell-engager","kind":"technology","name":"T-cell engagers (bispecific)","route":"/technologies/t-cell-engager/"}],"target":[{"id":"her2","kind":"target","name":"HER2","route":"/targets/her2/"}],"drug":[{"id":"trastuzumab","kind":"drug","name":"Trastuzumab","route":"/drugs/trastuzumab/"}],"institution":[{"id":"hospital-clinic-barcelona","kind":"institution","name":"Hospital Clínic de Barcelona / IDIBAPS","route":"/institutions/hospital-clinic-barcelona/"},{"id":"vall-dhebron","kind":"institution","name":"Vall d'Hebron University Hospital / VHIO","route":"/institutions/vall-dhebron/"}],"person":[{"id":"jaume-raventos-i-monjo","kind":"person","name":"Jaume Raventós i Monjo","route":"/people/jaume-raventos-i-monjo/"},{"id":"joaquin-arribas","kind":"person","name":"Joaquín Arribas","route":"/people/joaquin-arribas/"}]}}